Analyze Diet
Zentralblatt fur Veterinarmedizin. Reihe A1991; 38(3); 153-156; doi: 10.1111/j.1439-0442.1991.tb00996.x

Detomidine reduces the plasma catecholamine, but not cortisol concentrations in horses.

Abstract: Single doses of the alpha 2-adrenergic sedative-analgesic drug, detomidine (10 micrograms/kg, n = 7; 20 micrograms/kg, n = 9), were administered IV to adult horses. Plasma concentrations of adrenaline, noradrenaline, the catecholamine metabolites 3,4-dihydroxyphenylglycol (DHPG) and 3,4-dihydroxyphenylacetic acid (DOPAC), and cortisol were determined before the medication and 30 minutes after it. The plasma concentrations of noradrenaline and the catecholamine metabolites decreased significantly after administration of both 10 micrograms/kg and 20 micrograms/kg of detomidine. Plasma adrenaline level had a tendency to decrease, but plasma cortisol levels were not influenced. The findings suggest a reduction in sympatho-adrenal activity in horses treated with detomidine.
Publication Date: 1991-04-01 PubMed ID: 1907061DOI: 10.1111/j.1439-0442.1991.tb00996.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates the effects of the drug detomidine on horses, revealing that it lowers plasma catecholamine concentrations, but has no effect on cortisol levels, suggesting a reduction in sympatho-adrenal activity.

Introduction

The study revolves around analyzing the effects of single doses of detomidine, an alpha 2-adrenergic sedative-analgesic drug, on the concentrations of several substances in horse plasma. These substances include adrenaline, noradrenaline, two catecholamine metabolites (3,4-dihydroxyphenylglycol and 3,4-dihydroxyphenylacetic acid), and cortisol.

Methodology

  • The drug detomidine was administered intravenously to adult horses in two different dosages – 10 micrograms/kg (in seven horses) and 20 micrograms/kg (in nine horses).
  • The plasma concentrations of the mentioned substances were determined before and 30 minutes after the administration of the medication.

Results

  • Post-medication, a significant decrease in plasma concentrations of noradrenaline and the catecholamine metabolites was observed in the horses given both 10 micrograms/kg and 20 micrograms/kg of detomidine.
  • The levels of adrenaline in the plasma also showed a tendency to decrease following the administration of the drug, although this was not deemed statistically significant.
  • In contrast, the levels of cortisol, a hormone associated with stress responses, remained unaffected by the use of detomidine.

Conclusion

Based on the obtained results, it is concluded that detomidine reduces the sympatho-adrenal activity in horses. This is evident from the fact that the plasma concentrations of noradrenaline and catecholamine metabolites decreased significantly following the administration of detomidine. The lack of change in cortisol levels suggests that detomidine’s effects are specific to certain components of the stress response, rather than simply reducing stress levels overall. The findings are valuable for understanding how detomidine works and its potential impact on horses’ stress and pain responses.

Cite This Article

APA
Raekallio M, Vainio O, Scheinin M. (1991). Detomidine reduces the plasma catecholamine, but not cortisol concentrations in horses. Zentralbl Veterinarmed A, 38(3), 153-156. https://doi.org/10.1111/j.1439-0442.1991.tb00996.x

Publication

ISSN: 0514-7158
NlmUniqueID: 0331323
Country: Germany
Language: English
Volume: 38
Issue: 3
Pages: 153-156

Researcher Affiliations

Raekallio, M
  • College of Veterinary Medicine, Department of Clinical Sciences, Helsinki, Finland.
Vainio, O
    Scheinin, M

      MeSH Terms

      • Animals
      • Catecholamines / blood
      • Female
      • Horse Diseases / blood
      • Horses / blood
      • Hydrocortisone / blood
      • Imidazoles / pharmacology
      • Male
      • Stress, Physiological / blood
      • Stress, Physiological / veterinary

      Citations

      This article has been cited 2 times.
      1. Pakkanen SAE, de Vries A, Raekallio MR, Mykkänen AK, Palviainen MJ, Sankari SM, Vainio OM. Changes in energy metabolism, and levels of stress-related hormones and electrolytes in horses after intravenous administration of romifidine and the peripheral α-2 adrenoceptor antagonist vatinoxan. Acta Vet Scand 2018 May 9;60(1):27.
        doi: 10.1186/s13028-018-0380-xpubmed: 29743097google scholar: lookup
      2. Kanda T, Hikasa Y. Neurohormonal and metabolic effects of medetomidine compared with xylazine in healthy cats. Can J Vet Res 2008 Apr;72(3):278-86.
        pubmed: 18505192